News Releases

Date	Title	Additional Formats
November 30, 2020	Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Erosive Esophagitis Trial
November 27, 2020	Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences
November 19, 2020	Phathom Pharmaceuticals to Host Virtual Investor Day
November 13, 2020	Phathom Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
November 10, 2020	Phathom Pharmaceuticals Reports Third Quarter 2020 Results and Provides Update on Phase 3 Trials
September 9, 2020	Phathom Pharmaceuticals to Present at Morgan Stanley 18th Annual Global Healthcare Conference
August 6, 2020	Phathom Pharmaceuticals Reports Second Quarter 2020 Results
July 13, 2020	Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
June 15, 2020	Phathom Pharmaceuticals Provides Clinical Trial Status Update
May 28, 2020	Phathom Pharmaceuticals to Present at Upcoming Investor Conferences